BioPharm News

May 15, 2018
By BioPharm International Editors
Eli Lilly will acquire ARMO BioSciences to strengthen Lilly's immuno-oncology program.
May 14, 2018
By BioPharm International Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 14, 2018
By BioPharm International Editors
FDA sent a warning letter to Goran Pharma Private Limited citing inadequate quality control violations.
May 14, 2018
President Donald Trump announced his strategy for making prescription medicines more affordable and accessible in the United States.
May 10, 2018
By BioPharm International Editors
The agency is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for violating cGMP requirements.
May 10, 2018
By BioPharm International Editors
The companies have extended a contract agreement for the commercial manufacture of the active pharmaceutical ingredient for vonapanitase, an investigational drug intended to improve hemodialysis vascular access outcomes.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 09, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
May 09, 2018
By BioPharm International Editors
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 09, 2018
By BioPharm International Editors
InstantGMP INV is a validated software for real-time material tracking and inventory control in biopharmaceutical manufacturing.
native1_300x100
lorem ipsum